Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply

Affiliations

• ¹ IRCCS Ospedale San Raffaele and University Vita-Salute, San Raffaele, Milan, Italy.
• ² Gossamer, Bio, Inc., San Diego, California, USA.
• ³ Alimentiv Inc., London, ON, Canada.
• ⁴ ARENSIA Exploratory Medicine GmbH, Düsseldorf, Germany.
• ⁵ Nicolae Testemitanu State University of Medicine and Pharmacy, Chișinău, Moldova.
• ⁶ Delta Research Partners, Bastrop, Los Angeles, USA.
• ⁷ Mayo Clinic, Phoneix, Arizona, USA.
• ⁸ University of California San Diego, La Jolla, California, USA.